整合价格基准和比较临床有效性,为医疗保险药品价格谈判计划提供信息
Sean D Sullivan1, Olivier J Wouters2, Emma M Cousin3
1The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA; Department of Health Policy, London School of Economics and Political Science, London, England, UK.
概括
医疗保险和医疗补助服务中心 (CMS) 将很快报告谈判药物价格. 这项研究估计了最初的报价,使用净价格,上限和10种选定的药物的比较有效性数据.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 药品定价 药品定价 药品定价
背景情况:
- 医疗保险和医疗补助服务中心 (CMS) 准备在2024年9月之前公开报告10种选定的药物的最高公平价格.
- 这一举措标志着药品定价监管和透明度的重大转变.
研究的目的:
- 估计CMS首选10种药物的可信初始价格报价.
- 确定影响这些初始报价的关键价格基准和临床证据因素.
主要方法:
- 对10种药物及其治疗替代品的使用净价格,法定上限价格和比较有效性数据.
- 分析了CMS的指导和监管意图,以概述一系列潜在的初始价格报价.
主要成果:
- 法律上规定的上限价格很可能决定ibrutinib和ustekinumab的初始报价.
- 净价格和临床证据将为apixaban,empagliflozin,etanercept和胰岛素aspart的报价提供信息.
- 由于通用替代品,可能适用于利瓦罗克萨班和萨库比特里尔/瓦尔萨坦的折扣;对于达帕格利弗洛辛和西塔格利普丁,需要额外的因素.
结论:
- 该分析强调了关键的价格基准和临床证据,用于确定初始药品价格谈判报价.
- 提供了一个系统的方法来生成与CMS指导一致的初始报价,尽管没有模拟完整的谈判过程.
相关概念视频
Bioequivalence: Overview
949
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
949
Health Information Technology and Healthcare Information System
812
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
812
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Prescription, Nonprescription and Orphan Drugs
707
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
707
Agonism and Antagonism: Quantification
334
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
334
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
52
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
52


